Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

Director/PDMR Shareholding

29 Oct 2013 07:00

RNS Number : 5842R
W.H. Ireland Group PLC
29 October 2013
 



WH Ireland Group plc

 

("WH Ireland" or the "Company")

 

Director's dealing

 

WH Ireland announces that on 28 October 2013, Richard Killingbeck, Chief Executive Officer of the Company, and the WH Ireland Group plc Employee Share Ownership Trust ("ESOT") entered into a joint share ownership agreement ("JSOA") in relation to 1,000,000 ordinary shares of 5p each in the Company ("JSOA Shares").

 

Under the terms of the JSOA, Richard Killingbeck has an option to acquire the ESOT's interest in the JSOA Shares at a maximum price of £0.745 per Share (the "Exercise Price") at any time between 28 October 2016 and 28 October 2023. The Exercise Price is subject to a formula based on a total return to WH Ireland shareholders over a 3 year period. It is dependent on the mid-market price of an ordinary share of 5p in the Company (an "Ordinary Share") on 28 October 2016 together with the aggregate dividends paid on an Ordinary Share over the preceding 3 year period (the "3 Year Value"). The main terms of the formula are that, in the event that the 3 Year Value is:

 

· less than or equal to £1.15, the Exercise Price will be £0.745

· £2.00 or more, the Exercise Price will be nil; and

· between £1.15 and £2.00 the Exercise Price will decrease on a sliding scale from £0.745 to nil.

 

This arrangement replaces a binding commitment that WH Ireland entered into with Mr Killingbeck prior to his appointment as Chief Executive Officer of the Company, entitling him to be granted an option over 473,787 Ordinary Shares, the terms of which were contained in an announcement made by the Company on 12 November 2012.

 

Following entering into the JSOA, Mr. Killingbeck will hold the following interests in the share capital of the Company:

 

Number of Shares

Percentage of voting rights

Nature of holding

805,000

3.40%

Beneficial

1,000,000

n/a

Held jointly with the ESOT

19,565

n/a

SAYE Scheme*

 

* Under the WH Ireland Save As You Earn Scheme (SAYE), assuming Mr Killingbeck continues to contribute at the full amount defined in his savings contract, this is the maximum number of Ordinary Shares that Mr Killingbeck will have an option to acquire under the terms of the SAYE.

 

For further information please contact:

WH Ireland Group plc

+44 (0) 20 7220 1666

Rupert Lowe, Chairman

Richard Killingbeck, CEO

Panmure Gordon (UK) Limited

+44 (0)20 7886 2500

Hugh Morgan (Corporate Finance)

Adam Pollock (Corporate Broking)

Abchurch Communications

+44 (0)20 7398 7718

Harriet Rae/Joanne Shears/Julian Bosdet

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFSAISLTFIV
Date   Source Headline
18th Dec 20197:05 amRNSIssue of Options
18th Dec 20197:00 amRNSDirectorate Change - Update
21st Nov 201910:58 amRNSResult of General Meeting
8th Nov 20194:00 pmRNSConfirmation of General Meeting
7th Nov 20197:00 amRNSWH Ireland CIB announces three new appointments
6th Nov 20194:20 pmRNSResult of Placing
6th Nov 20197:10 amRNSProposed Placing
6th Nov 20197:05 amRNSInterim Results
6th Nov 20197:00 amRNSBoard Appointments
23rd Oct 20197:00 amRNSHolding(s) in Company
23rd Oct 20197:00 amRNSHolding(s) in Company
4th Oct 20197:00 amRNSBoard Changes
27th Sep 20197:00 amRNSDirectorate Change - Update
12th Sep 20192:53 pmRNSResult of AGM
20th Aug 20197:00 amRNSDirectorate Change & Updated Notice of AGM
2nd Aug 20197:00 amRNSDirector/PDMR Shareholding
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
31st Jul 20197:00 amRNSFinal Results & Notice of AGM
23rd Jul 20197:00 amRNSBoard Appointment
28th Jun 201912:13 pmRNSIssue of Options
25th Jun 20199:19 amRNSDirector/PDMR Shareholding
24th Jun 20197:00 amRNSDirectorate Change Update
13th May 20192:26 pmRNSDirectorate Change Update
24th Apr 20197:00 amRNSDirector/PDMR Shareholding
8th Apr 20197:00 amRNSDirector/PDMR Shareholding
4th Apr 20197:00 amRNSDirector/PDMR Shareholding
29th Mar 20197:00 amRNSBoard appointment
26th Mar 20194:44 pmRNSHolding(s) in Company
26th Mar 201910:32 amRNSHolding(s) in Company
21st Mar 20191:59 pmRNSResult of General Meeting
13th Mar 201910:59 amRNSHolding(s) in Company
5th Mar 20194:21 pmRNSResult of Placing and Notice of General Meeting
5th Mar 20197:00 amRNSProposed Placing
6th Feb 20197:00 amRNSDirectorate Changes and Trading Update
21st Dec 20187:00 amRNSDirectorate Change Update
12th Dec 20187:00 amRNSAppointment of New Head of Wealth Management
28th Nov 20187:00 amRNSDirectorate Change
28th Nov 20187:00 amRNSInterim Results
17th Oct 20189:42 amRNSConfirmation of Appointment of CEO
12th Oct 20187:00 amRNSHolding(s) in Company
11th Oct 20182:52 pmRNSHolding(s) in Company
11th Oct 20181:29 pmRNSHolding(s) in Company
10th Oct 20185:10 pmRNSHolding(s) in Company
9th Oct 201811:07 amRNSResult of General Meeting
27th Sep 201812:36 pmRNSResult of AGM & Confirmation of Directorate Change
24th Sep 20184:45 pmRNSHolding(s) in Company
24th Sep 20184:43 pmRNSHolding(s) in Company
20th Sep 201810:36 amRNSShareholder Update, Placing and Notice of GM
20th Sep 201810:35 amRNSHolding(s) in Company
20th Sep 201810:35 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.